Drugs / Maixuekang capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06823895 | Sep 2024 → Dec 2026 expected | — | Nanfang Hospital, Southern Medical University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Maixuekang Capsule | “"Maixuekang Capsule" is a traditional Chinese patent medicines and simple preparations approved by the State Food and Drug Administration of China, which has been used for more...” NCT06823895 ↗ |
| Route | Oral | “Participants will be given Maixuekang capsules once, 1g, orally.” NCT06823895 ↗ |